FDMT vs LEN
4D Molecular Therapeutics Inc (FDMT) versus LEN (LEN) — a side-by-side from cached financials, not a winner call.
4D Molecular Therapeutics Inc (FDMT) is a biotechnology company listed on US.
LEN (LEN) common stock.
Latest reported FDMT revenue for 2024-12-31 was $37.0K. Net income was -$160.9M. Revenue was down 99.8% from 2023-12-31 to 2024-12-31. FDMT currently screens at market cap $518.1M.
LEN does not have a complete income-statement cache yet.
FDMT currently screens at market cap $518.1M. LEN currently screens at market cap $0.
Not investment advice. Open the FDMT and LEN stock pages for the full models.
Not investment advice.